Edward White
Stock Analyst at HC Wainwright & Co.
(2.12)
# 2,801
Out of 4,761 analysts
368
Total ratings
33.33%
Success rate
-1.78%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DVAX Dynavax Technologies | Reiterates: Buy | $31 | $13.33 | +132.56% | 21 | Feb 21, 2025 | |
| KPTI Karyopharm Therapeutics | Reiterates: Buy | $7 | $0.60 | +1,069.79% | 27 | Feb 20, 2025 | |
| VALN Valneva SE | Maintains: Buy | $18 → $17 | $7.44 | +128.49% | 34 | Feb 19, 2025 | |
| CMRX Chimerix | Reiterates: Buy | $11 | $5.15 | +113.59% | 17 | Feb 18, 2025 | |
| IKT Inhibikase Therapeutics | Downgrades: Neutral | n/a | $2.97 | - | 10 | Feb 12, 2025 | |
| ACET Adicet Bio | Reiterates: Neutral | n/a | $0.97 | - | 21 | Feb 5, 2025 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $28 → $33 | $9.03 | +265.45% | 22 | Jan 29, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $1.82 | +229.67% | 14 | Jan 29, 2025 | |
| LRMR Larimar Therapeutics | Reiterates: Buy | $15 | $3.19 | +370.22% | 6 | Jan 24, 2025 | |
| IFRX InflaRx | Reiterates: Buy | $8 | $1.83 | +337.16% | 23 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $30.88 | +78.11% | 30 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $1.25 | +1,180.00% | 12 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.45 | - | 9 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.45 | +788.30% | 5 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.77 | +430.50% | 1 | Dec 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.91 | +140.96% | 19 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $10.35 | +64.30% | 13 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.10 | +545.16% | 17 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $16.38 | +211.36% | 28 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.51 | +192.94% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.49 | - | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $8.44 | - | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.29 | - | 12 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.76 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $0.53 | +5,151.31% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $21.85 | +37.30% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.42 | +745.07% | 2 | Mar 6, 2018 |
Dynavax Technologies
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $13.33
Upside: +132.56%
Karyopharm Therapeutics
Feb 20, 2025
Reiterates: Buy
Price Target: $7
Current: $0.60
Upside: +1,069.79%
Valneva SE
Feb 19, 2025
Maintains: Buy
Price Target: $18 → $17
Current: $7.44
Upside: +128.49%
Chimerix
Feb 18, 2025
Reiterates: Buy
Price Target: $11
Current: $5.15
Upside: +113.59%
Inhibikase Therapeutics
Feb 12, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.97
Upside: -
Adicet Bio
Feb 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.97
Upside: -
Cullinan Therapeutics
Jan 29, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $9.03
Upside: +265.45%
SAB Biotherapeutics
Jan 29, 2025
Reiterates: Buy
Price Target: $6
Current: $1.82
Upside: +229.67%
Larimar Therapeutics
Jan 24, 2025
Reiterates: Buy
Price Target: $15
Current: $3.19
Upside: +370.22%
InflaRx
Jan 16, 2025
Reiterates: Buy
Price Target: $8
Current: $1.83
Upside: +337.16%
Jan 15, 2025
Reiterates: Buy
Price Target: $55
Current: $30.88
Upside: +78.11%
Jan 13, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $1.25
Upside: +1,180.00%
Jan 10, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.45
Upside: -
Jan 10, 2025
Reiterates: Buy
Price Target: $4
Current: $0.45
Upside: +788.30%
Dec 30, 2024
Initiates: Buy
Price Target: $20
Current: $3.77
Upside: +430.50%
Dec 23, 2024
Reiterates: Buy
Price Target: $7
Current: $2.91
Upside: +140.96%
Dec 13, 2024
Reiterates: Buy
Price Target: $17
Current: $10.35
Upside: +64.30%
Dec 10, 2024
Reiterates: Buy
Price Target: $20
Current: $3.10
Upside: +545.16%
Dec 10, 2024
Reiterates: Buy
Price Target: $51
Current: $16.38
Upside: +211.36%
Nov 14, 2024
Reiterates: Buy
Price Target: $22
Current: $7.51
Upside: +192.94%
Nov 13, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.49
Upside: -
Oct 24, 2024
Initiates: Neutral
Price Target: n/a
Current: $8.44
Upside: -
Jun 4, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.29
Upside: -
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.76
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $0.53
Upside: +5,151.31%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $21.85
Upside: +37.30%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.42
Upside: +745.07%